- MSKCC’s Howard Scher presented findings for the investigational oral drug MDV3100 at the 2012 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium.
- Dr. Monica Morrow of MSKCC was quoted in a New York Times article about a study that examined the outcomes of breast cancer surgeries in women from four institutions and three health plans.
- MSKCC researchers reported that a scale used to measure bone metastases has been found useful in determining whether some prostate cancer patients are responding to chemotherapy. The study was published in the Journal of Clinical Oncology.